RecruitingNCT04473794

Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts


Sponsor

Johns Hopkins University

Enrollment

5,000 participants

Start Date

Jul 20, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The aims of this study are to determine the natural history of pancreatic cysts and to propose and prospectively validate a diagnostic approach and model for prediction of mucinous versus non-mucinous, and malignant versus non-malignant, pancreatic cysts using a combination of clinical, radiologic, and biomarker characteristics.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is following patients with pancreatic cysts — small fluid-filled sacs in the pancreas — over time to better understand which cysts are likely to become cancerous and which are harmless. Because most pancreatic cysts are benign but some can turn into cancer, better risk assessment is urgently needed. **You may be eligible if:** - You are 18 or older - You have been referred for evaluation of a pancreatic cyst **You may NOT be eligible if:** - You are classified as medically very ill (ASA class 4 or higher — typically means a life-threatening condition) - You are unable to give informed consent - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

The Johns Hopkins Hospital

Baltimore, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04473794


Related Trials